Euan A. Stronach
Age UK(GB)
Publications by Year
Research Areas
PARP inhibition in cancer therapy, Ovarian cancer diagnosis and treatment, Cancer-related molecular mechanisms research, CRISPR and Genetic Engineering, Biosimilars and Bioanalytical Methods
Most-Cited Works
- → Whole–genome characterization of chemoresistant ovarian cancer(2015)1,618 cited
- → Rethinking ovarian cancer: recommendations for improving outcomes(2011)1,500 cited
- → Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer(2015)1,397 cited
- → Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens(2019)1,391 cited
- → Oxidative metabolism drives inflammation-induced platinum resistance in human ovarian cancer(2016)199 cited
- → HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer(2011)179 cited
- → OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer(2003)178 cited
- → Unsupervised correction of gene-independent cell responses to CRISPR-Cas9 targeting(2018)142 cited
- → DNA-PK Mediates AKT Activation and Apoptosis Inhibition in Clinically Acquired Platinum Resistance(2011)138 cited
- → Functional linkage of gene fusions to cancer cell fitness assessed by pharmacological and CRISPR-Cas9 screening(2019)131 cited